French Disease Specialist Successfully Cures 75% Of His 24 COVID-19 Patients With Malaria Drug

Massarat Fikria / Facebook

A world-class French professor named Didier Raoult has just completed a trial that is showing promising signs of reducing the symptoms of COVID-19 and potentially curing the extremely dangerous virus.

Didier is an infectious disease specialist who is head of the IHU Méditerranée Infection in Marseille, France and he just published a video on March 16, 2020, explaining the success he had in a trial he conducted in attempts to cure his patients of the disease.

In the trial, he used a drug containing hydroxychloroquine on patients who tested positive for COVID-19 and it rapidly sped up the healing process and amount of time the patients remained contagious. Hydroxychloroquine is a drug that was previously used to treat malaria and it also goes by the prescription drug name, Plaquenil.

During the trial, 24 voluntary patients who came from infected areas of southeast France were given 600mcg of Plaquenil per day for 10 days straight. The French professor said after 6 days only 25% of the patients were still contagious.

“We were able to ascertain that patients who had not received Plaquenil (the drug containing hydroxychloroquine) were still contagious after six days, but of those that had received Plaquenil, after six days, only 25% were still contagious.” Connexion France reported the professor saying in the video.

According to Worldometer, as of March 19th, 2020, the United States has reported 13,475 cases of people who tested positive for COVID-19 and 187 people have died from it.

That number is expected to grow, however, with medical trial testing being done worldwide to find a cure and with the French professor’s new findings we can expect that governments everywhere will be figuring out solutions to reduce symptoms and/or cure the infectious virus.

In fact, President Donald Trump also spoke today in a press conference about hydroxychloroquine and another drug called Remsdesivir that may be a potential “game-changer” for curing the disease.

“And I think it’s going to be very exciting. I think it could be a game changer. And maybe not. Maybe not, but I think it could be, based on what I see, it could be a game changer. Very powerful, they’re very powerful,” Trump said during the press conference.

Video Below Explains More On The Professor’s Successful Drug Trial